Amarin (AMRN) Price & Analysis

Compare

3,242 Followers

AMRN Stock Chart & Stats

Day’s Range― - ―

52-Week Range$7.08 - $17.49

Previous CloseN/A

Volume726.09K

Average Volume (3M)96.91K

Market Cap

$314.25M

Enterprise Value$44.47M

Total Cash (Recent Filing)$298.70M

Total Debt (Recent Filing)$7.34M

Price to Earnings (P/E)―

Beta1.58

Next Earnings

Oct 29, 2025

EPS Estimate

-0.39

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.03

Shares Outstanding20,682,775

10 Day Avg. Volume67,451

30 Day Avg. Volume96,912

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.14

Enterprise Value/Revenue0.23

Enterprise Value/Gross Profit0.54

Enterprise Value/Ebitda-0.46

Forecast

1Y Price Target

$11.00

Price Target Upside-27.30% Downside

Rating ConsensusModerate Sell

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Business Model RestructuringThe Recordati partnership in Europe helps reshape Amarin's business model by transferring commercialization to a seasoned local partner with established cardiovascular infrastructure and expertise.

Revenue GrowthThe total revenues included a $25M upfront payment from the Recordati deal, contributing to the overall revenue growth.

Bears Say

Generic CompetitionThe US Vascepa franchise continues to face significant competitive pressure from at least eight generic competitors, with gross margins declining to 41% in 4Q24 vs 58% in 4Q23.

Market PressureThe business mix has shifted more toward Medicare Part D following CVS's decision to no longer cover Vascepa as the exclusive IPE product, creating additional net pricing pressure.

Amarin News

Amarin reports Q2 adjusted EPS 4c vs. 1c last year

Reports Q2 revenue $72.7M vs. $67.5M last year. “The strategic actions taken in the second quarter – our...

9d ago

AMRN

Amarin expects accelerated in-market demand in Europe

Commenting on the quarter and current state of the business, Peter Fishman, Amarin’s (AMRN) Chief Financial Officer said,...

9d ago

AMRN

Amarin’s Strategic Shift and Market Challenges Justify Hold Rating

In a report released on July 30, Roanna Ruiz from Leerink Partners maintained a Hold rating on Amarin,...

7d ago

AMRN

Amarin Corporation Reports Q2 2025 Financial Results

Amarin Corporation Plc ( ($AMRN) ) has released its Q2 earnings. Here is a breakdown of the information...

9d ago

AMRN

Amarin Corporation’s Earnings Call Highlights Growth Amid Challenges

Amarin Corporation Plc (($AMRN)) has held its Q2 earnings call. Read on for the main highlights of the...

9d ago

AMRN

AMRN Earnings this Week: How Will it Perform?

Amarin Corporation Plc (AMRN) is scheduled to report 2nd quarter earnings on 07/30/2025, before the market opens. Regarding...

11d ago

AMRN

Amarin Enters Licensing Agreement with Recordati

Amarin ( ($AMRN) ) just unveiled an announcement. On June 20, 2025, Amarin Corporation entered into a long-term...

2M ago

AMRN

Amarin announces exclusive license, supply agreement with Recordati

Amarin (AMRN) announced that the Company has entered into an exclusive long-term license and supply agreement with Recordati...

2M ago

AMRN

Amarin Shareholders Reject Key Proposal at AGM

Amarin ( ($AMRN) ) has issued an update. At Amarin Corporation’s Annual General Meeting on May 13, 2025,...

3M ago

AMRN

Amarin’s Market Position: Balancing European Growth and US Challenges

Analyst Roanna Ruiz from Leerink Partners maintained a Hold rating on Amarin (AMRN – Research Report) and increased...

3M ago

AMRN

Amarin Corporation Reports Q1 2025 Financial Results

Amarin Corporation Plc ( ($AMRN) ) has released its Q1 earnings. Here is a breakdown of the information...

3M ago

AMRN

Amarin Corporation’s Earnings Call Highlights Global Expansion

Amarin Corporation Plc (($AMRN)) has held its Q1 earnings call. Read on for the main highlights of the...

3M ago

AMRN

Amarin reports Q1 EPS (2) vs (1c) last year

Reports Q1 revenue $41M vs $55M last year. “As we begin 2025, our first quarter operational and financial...

3M ago

AMRN

Amarin Regains Nasdaq Compliance with Share Adjustment

The latest update is out from Amarin ( ($AMRN) ). On April 29, 2025, Amarin Corporation announced it...

3M ago

AMRN

AMRN FAQ

What was Amarin Corporation Plc’s price range in the past 12 months?

Amarin Corporation Plc lowest stock price was $7.08 and its highest was $17.49 in the past 12 months.

What is Amarin Corporation Plc’s market cap?

Amarin Corporation Plc’s market cap is $314.25M.

When is Amarin Corporation Plc’s upcoming earnings report date?

Amarin Corporation Plc’s upcoming earnings report date is Oct 29, 2025 which is in 82 days.

How were Amarin Corporation Plc’s earnings last quarter?

Amarin Corporation Plc released its earnings results on Jul 30, 2025. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.25 by $0.22.

Is Amarin Corporation Plc overvalued?

According to Wall Street analysts Amarin Corporation Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Amarin Corporation Plc pay dividends?

Amarin Corporation Plc does not currently pay dividends.

What is Amarin Corporation Plc’s EPS estimate?

Amarin Corporation Plc’s EPS estimate is -0.39.

How many shares outstanding does Amarin Corporation Plc have?

Amarin Corporation Plc has 20,682,775 shares outstanding.

What happened to Amarin Corporation Plc’s price movement after its last earnings report?

Amarin Corporation Plc reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.25. Following the earnings report the stock price went up 2.184%.

Which hedge fund is a major shareholder of Amarin Corporation Plc?

Currently, no hedge funds are holding shares in AMRN

Amarin Stock Smart Score

Neutral

Fundamentals

Return on Equity

-20.38%

Trailing 12-Months

Asset Growth

-16.22%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Amarin Corporation Plc

Amarin Corporation plc (AMRN) is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to improve cardiovascular health. The company is primarily known for its flagship product, Vascepa (icosapent ethyl), an omega-3 fatty acid derived prescription medication designed to reduce cardiovascular risk in patients with elevated triglyceride levels. Amarin operates within the pharmaceutical and biotechnology sectors, focusing on innovations that address unmet needs in cardiovascular health management.

Amarin (AMRN) Earnings & Revenues

Historic Earnings Reports

AMRN Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call presented a positive outlook, with strategic partnerships, global expansion, and financial strength highlighting growth potential. However, challenges remain in the U.S. market due to pricing pressures and revenue decline.View all AMRN earnings summaries

AMRN Stock 12 Month Forecast

Average Price Target

$11.00

▼(-27.30% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"$7","22":"$22","10.75":"$10.75","14.5":"$14.5","18.25":"$18.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$12.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$10.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,10.75,14.5,18.25,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.16,14.916923076923077,14.673846153846155,14.430769230769231,14.187692307692307,13.944615384615386,13.701538461538462,13.458461538461538,13.215384615384615,12.972307692307693,12.72923076923077,12.486153846153847,12.243076923076924,{"y":12,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.16,14.84,14.52,14.2,13.88,13.56,13.24,12.92,12.6,12.280000000000001,11.96,11.64,11.32,{"y":11,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.16,14.763076923076923,14.366153846153846,13.96923076923077,13.572307692307692,13.175384615384615,12.778461538461539,12.381538461538462,11.984615384615385,11.587692307692308,11.19076923076923,10.793846153846154,10.396923076923077,{"y":10,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":21.2,"date":1709251200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":16.79,"date":1714521600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.72,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":12.43,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.72,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":10.51,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":9.7,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":10.84,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.84,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":10.98,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.74,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":16.81,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":15.16,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >